BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 26116511)

  • 1. Control of Viremia Enables Acquisition of Resting Memory B Cells with Age and Normalization of Activated B Cell Phenotypes in HIV-Infected Children.
    Muema DM; Macharia GN; Hassan AS; Mwaringa SM; Fegan GW; Berkley JA; Nduati EW; Urban BC
    J Immunol; 2015 Aug; 195(3):1082-91. PubMed ID: 26116511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low Peripheral T Follicular Helper Cells in Perinatally HIV-Infected Children Correlate With Advancing HIV Disease.
    McCarty B; Mwamzuka M; Marshed F; Generoso M; Alvarez P; Ilmet T; Kravietz A; Ahmed A; Borkowsky W; Unutmaz D; Khaitan A
    Front Immunol; 2018; 9():1901. PubMed ID: 30197641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Innate immune defects correlate with failure of antibody responses to H1N1/09 vaccine in HIV-infected patients.
    Pallikkuth S; Kanthikeel SP; Silva SY; Fischl M; Pahwa R; Pahwa S
    J Allergy Clin Immunol; 2011 Dec; 128(6):1279-85. PubMed ID: 21752440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Memory B-cell depletion is a feature of HIV-2 infection even in the absence of detectable viremia.
    Tendeiro R; Fernandes S; Foxall RB; Marcelino JM; Taveira N; Soares RS; Baptista AP; Cavaleiro R; Gomes P; Victorino RM; Sousa AE
    AIDS; 2012 Aug; 26(13):1607-17. PubMed ID: 22695303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for HIV-associated B cell exhaustion in a dysfunctional memory B cell compartment in HIV-infected viremic individuals.
    Moir S; Ho J; Malaspina A; Wang W; DiPoto AC; O'Shea MA; Roby G; Kottilil S; Arthos J; Proschan MA; Chun TW; Fauci AS
    J Exp Med; 2008 Aug; 205(8):1797-805. PubMed ID: 18625747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concerted effect of lymphopenia, viraemia and T-cell activation on Fas expression of peripheral B cells in HIV-1-infected patients.
    Rethi B; Sammicheli S; Amu S; Pensieroso S; Hejdeman B; Schepis D; Thang PH; Chiodi F
    AIDS; 2013 Jan; 27(2):155-62. PubMed ID: 23238551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone marrow plasma cells are a primary source of serum HIV-1-specific antibodies in chronically infected individuals.
    Montezuma-Rusca JM; Moir S; Kardava L; Buckner CM; Louie A; Kim LJ; Santich BH; Wang W; Fankuchen OR; Diaz G; Daub JR; Rosenzweig SD; Chun TW; Li Y; Braylan RC; Calvo KR; Fauci AS
    J Immunol; 2015 Mar; 194(6):2561-8. PubMed ID: 25681347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Homing defects of B cells in HIV-1 infected children impair vaccination responses.
    Bekele Y; Lemma M; Bobosha K; Yibeltal D; Nasi A; Gebre M; Nilsson A; Aseffa A; Howe R; Chiodi F
    Vaccine; 2019 Apr; 37(17):2348-2355. PubMed ID: 30914222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B-cell subset alterations and correlated factors in HIV-1 infection.
    Pensieroso S; Galli L; Nozza S; Ruffin N; Castagna A; Tambussi G; Hejdeman B; Misciagna D; Riva A; Malnati M; Chiodi F; Scarlatti G
    AIDS; 2013 May; 27(8):1209-17. PubMed ID: 23343911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deleterious effect of HIV-1 plasma viremia on B cell costimulatory function.
    Malaspina A; Moir S; Kottilil S; Hallahan CW; Ehler LA; Liu S; Planta MA; Chun TW; Fauci AS
    J Immunol; 2003 Jun; 170(12):5965-72. PubMed ID: 12794123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of HIV infection and highly active antiretroviral therapy (HAART) on B cell subpopulations in children.
    Singh R; Mukherjee A; Singla M; Vajpayee M; Negi N; Kabra SK; Lodha R; Das BK
    J Med Virol; 2018 Jul; 90(7):1222-1231. PubMed ID: 29575050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Memory B cell function in HIV-infected children-decreased memory B cells despite ART.
    Ghosh S; Feyen O; Jebran AF; Huck K; Jetzek-Zader M; Bas M; Niehues T
    Pediatr Res; 2009 Aug; 66(2):185-90. PubMed ID: 19390488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of BAFF Blockade on Inflammation, Germinal Center Reaction and Effector B-Cells During Acute SIV Infection.
    Borhis G; Trovato M; Ibrahim HM; Isnard S; Le Grand R; Bosquet N; Richard Y
    Front Immunol; 2020; 11():252. PubMed ID: 32194549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alteration of B cell subsets and the receptor for B cell activating factor (BAFF) in paediatric patients with type 1 diabetes.
    Parackova Z; Klocperk A; Rataj M; Kayserova J; Zentsova I; Sumnik Z; Kolouskova S; Sklenarova J; Pruhova S; Obermannova B; Petruzelkova L; Lebl J; Kalina T; Sediva A
    Immunol Lett; 2017 Sep; 189():94-100. PubMed ID: 28414179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased mutation frequencies among immunoglobulin G variable region genes during viremic HIV-1 infection.
    Bowers E; Scamurra RW; Asrani A; Beniguel L; MaWhinney S; Keays KM; Thurn JR; Janoff EN
    PLoS One; 2014; 9(1):e81913. PubMed ID: 24409278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decrease in Numbers of Naive and Resting B Cells in HIV-Infected Kenyan Adults Leads to a Proportional Increase in Total and
    Frosch AE; Odumade OA; Taylor JJ; Ireland K; Ayodo G; Ondigo B; Narum DL; Vulule J; John CC
    J Immunol; 2017 Jun; 198(12):4629-4638. PubMed ID: 28526680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effective B cell activation in vitro during viremic HIV-1 infection with surrogate T cell stimulation.
    Nicholson LK; Pratap H; Bowers E; Gunzburger E; Bandi SR; Gardner EM; Palmer BE; Wright T; Kittelson J; Janoff EN
    Immunobiology; 2018 Dec; 223(12):839-849. PubMed ID: 30219203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BAFF and BAFF receptor levels correlate with B cell subset activation and redistribution in controlled human malaria infection.
    Scholzen A; Teirlinck AC; Bijker EM; Roestenberg M; Hermsen CC; Hoffman SL; Sauerwein RW
    J Immunol; 2014 Apr; 192(8):3719-29. PubMed ID: 24646735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of rituximab on B cell phenotype and serum B cell-activating factor levels in patients with thrombotic thrombocytopenic purpura.
    Becerra E; Scully MA; Leandro MJ; Heelas EO; Westwood JP; De La Torre I; Cambridge G
    Clin Exp Immunol; 2015 Mar; 179(3):414-25. PubMed ID: 25339550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B-cell development and pneumococcal immunity in vertically acquired HIV infection.
    Eisen S; Hayden C; Young CJ; Gilson R; Jungmann E; Jacobsen MC; Poulsom H; Goldblatt D; Klein NJ; Baxendale HE
    AIDS; 2016 Jul; 30(12):1867-76. PubMed ID: 27124901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.